key: cord-0659681-1cbfflgr authors: Fu, Yanwei; Li, Feng; Fustel, Paula boned; Zhao, Lei; Jia, Lijie; Zheng, Haojie; Sun, Qiang; Rong, Shisong; Tang, Haicheng; Xue, Xiangyang; Yang, Li; Li, Hong; Wang, Jiao Xie Wenxuan; Li, Yuan; Wang, Wei; Pei, Yantao; Wang, Jianmin; Wu, Xiuqi; Zheng, Yanhua; Tian, Hongxia; Gu, Mengwei title: The Report on China-Spain Joint Clinical Testing for Rapid COVID-19 Risk Screening by Eye-region Manifestations date: 2021-09-18 journal: nan DOI: nan sha: 4df1300710549dd7a2d161413bc5c4a6117d0b54 doc_id: 659681 cord_uid: 1cbfflgr Background: The worldwide surge in coronavirus cases has led to the COVID-19 testing demand surge. Rapid, accurate, and cost-effective COVID-19 screening tests working at a population level are in imperative demand globally. Methods: Based on the eye symptoms of COVID-19, we developed and tested a COVID-19 rapid prescreening model using the eye-region images captured in China and Spain with cellphone cameras. The convolutional neural networks (CNNs)-based model was trained on these eye images to complete binary classification task of identifying the COVID-19 cases. The performance was measured using area under receiver-operating-characteristic curve (AUC), sensitivity, specificity, accuracy, and F1. The application programming interface was open access. Findings: The multicenter study included 2436 pictures corresponding to 657 subjects (155 COVID-19 infection, 23.6%) in development dataset (train and validation) and 2138 pictures corresponding to 478 subjects (64 COVID-19 infections, 13.4%) in test dataset. The image-level performance of COVID-19 prescreening model in the China-Spain multicenter study achieved an AUC of 0.913 (95% CI, 0.898-0.927), with a sensitivity of 0.695 (95% CI, 0.643-0.748), a specificity of 0.904 (95% CI, 0.891 -0.919), an accuracy of 0.875(0.861-0.889), and a F1 of 0.611(0.568-0.655). Interpretation: The CNN-based model for COVID-19 rapid prescreening has reliable specificity and sensitivity. This system provides a low-cost, fully self-performed, non-invasive, real-time feedback solution for continuous surveillance and large-scale rapid prescreening for COVID-19. Funding: This project is supported by Aimomics (Shanghai) Intelligent The Coronavirus disease 2019 has affected more than a billion people with unprecedented public health and economic costs. In the battle of controlling infections, the first and critical step is to identify new outbreaks of coronavirus infections. Using polymerase chain reaction (PCR) based nucleic acid detection is the "golden standard" with high sensitivity and good specificity. However, the PCR detection requires significant time and hardware investments which can be prohibitory for rapid screening purposes. Therefore, several rapid screening tests have been utilized to identify potential COVID-19 cases, including direct body temperature measurement, symptom assessment, travel and exposure history review, and combinations of the above-mentioned tests. However, all these rapid screening tests suffer from a hugely variable sensitivity in detecting COVID-19 cases 1 . Approximately 80% of the published studies reported a sensitivity of <50% in different target populations and scenarios 2 . Therefore, a rapid, accurate, and cost-effective COVID -19 screening tests working at a population level is in imperative demand globally. A spectrum of extrapulmonary manifestations of COVID-19 have been reported, including ocular symptoms 3, 4 . These ocular symptoms consist of a wide range of manifestations in the eyelid, ocular surface, anterior segment, and the posterior segment of the eye [5] [6] [7] [8] . The prevalence of ocular symptoms in COVID-19 cases reportedly ranged from 0 to 38% with an average prevalence of 11% 9 . The ocular manifestations as first presenting symptom or only symptom of COVID-19 were reported in up to 10% of COVID-19 cases 5,6,10 . These findings suggested that ocular symptoms could manifest specific features in symptomatic and even in presymptomatic COVID-19 patients. Although the clinical significance of ocular symptoms has yet to be fully elucidated [9] [10] [11] , the typical ocular symptoms provide useful information to recognize the potential infectious cases. Artificial intelligence (AI) and machine learning, particularly image-based deep-learning models with convolutional neural networks (CNNs), have shown promising performance in disease classifications and risk assessments 12, 13 . However, these AI systems require Computed Tomography scans in hospital settings, which are not available for screening tests at a population level. In this study, we developed and tested a rapid eye-image-based AI system, setting in a smartphone, to identify potential COVID-19 infection in three independent cohorts including two from China and one from Spain. The study was conducted in accordance with of the Declaration of Helsinki. China. It is the national demonstrative base for prevention and treatment of liver diseases, the quality control center in Hebei province for diagnosis and treatment of AIDS, and the designated hospital for diagnosis and treatment of COVID-19 cases in Shijiazhuang city, China. Fever isolation ward is an emergency department established during the pandemic. The Department of Ophthalmology at the University and Polytechnic Hospital La Fe is a leading eye care provider, educator and researcher in Spain. All the COVID-19 patients were enrolled by DOUPH through collaboration with department of microbiology. The first phase of data collection was completed from April 1 st 2020 to June 7 th 2021 at the SPHCC and DOUPH, which generated the development dataset. Development dataset was randomly divided into an independent training dataset and a validation dataset after considering the sample sizes and COVID-19 cases in each dataset. The training dataset was used to develop the model and the validation dataset was used to determine the best hyper-parameters and threshold (a score above the threshold is classified as positive). The second phase of the data collection was completed during June 1 st 2020 and June 11 th at the SPHCC, FHS and DOUPH. This dataset was used to test the performance of the models. Controls were enrolled from each center during the corresponding phases of enrollment. The control dataset from SPHCC included subjects with non-COVID-19 lung diseases (NCLD), ocular diseases and healthy volunteers. NCLD included bronchopneumonia, chronic obstructive pulmonary diseases, pulmonary fungal infection and lung cancer. Ocular diseases included trachoma, pinkeye, conjunctivitis, glaucoma, cataract and keratitis. All healthy volunteers received physical examinations, had no abnormal clinical findings, and had no contact history with COVID-19 patients. In the FHS dataset, controls included patients fully recovered from COVID-19 (nuclear acid negative), patients with HBV (HBV DNA positive) and healthy subjects. In DOUPH dataset. All the control subjects were tested negative for COVID-19 nucleic acids during the study period. No death events were observed in this study. We conducted a study on the CNN-based model, using eye-region photos to screen for COVID-19 patients (Figure 1) . For each participant, normally 3-5 photographs of the ocular surface were taken using smart mobile phone CCD and CMOS cameras, assisted by doctors or healthcare workers. The same shooting mode and parameters were used during image capturing. And all shooting filters were avoided. All photos were captured in a good lighting condition, and not in a dark or red background. The image resolution was at least 1900x500 pixels at 96dpi. The average time for taking a set of 5 eye photos was around 1 minute. In the re-examination step, all the photos are examined by human for the second time, the data that failed to reveal the details of the eyes were discarded. In this study, the images from Shanghai were captured by different mobile photos, including HONOR Play 3, MAIMANG 8, HUAWEI Mate 9, OPPO R15, HONOR Magic 2s, and iPhone 8Plus. The images from Hebei were captured by Xiaomi 8, iPhone 7Plus, Huawei PRA-AL00X and Huawei ANA-AN00. The images from Spain were captured by OPPO A37f, Samsung SM-A920F and iPhone SE 2 nd . The schematic of our proposed model is illustrated in Figure 2 , which consists of two components, the Image Preprocessing 14 and Classification Networks. Specifically, the Image Preprocessing received raw eye-region images, and prepared them for model training or inference. The Classification Network was built upon the deep learning architecture for the classification. It studied the characteristics of eye-region according to the inputs, and learnt discriminatory texture and semantic embeddings in a high-dimension space. Finally, the risk assessment of COVID-19 was predicted. During training, to avoid overfitting, the random crop and early stop strategies were applied. The developing process of classification network had been divided into training and testing stages as shown in Fig. 1 . In the training stage, the classification network was evaluated on the validation dataset and was used to determine the hyperparameters, the threshold was determined by the best F1 score. In the testing stage, the model's performance (AUC, sensitivity, specificity, accuracy, F1) was measured using the test dataset with the determined threshold. Considering that a subject may have more than one available image, we classified each subject based on the prediction results of multiple images 15 . Therefore, we conduct the risk screening for subject based on the previous image-level predictions. To enhance the robustness or sensitivity, we developed two vote strategies: mean-voting and max-voting were applied. In the mean-voting method, the image-level prediction scores were averaged to the final score. In the max-voting method the highest image-level prediction score was used as the final score which resulted in a higher sensitivity. To measure the performance of the binary classification network, we calculated the area under the receiver-operating-characteristic curve (AUC), sensitivity, specificity, and accuracy according of our classification network. Bootstrapping with 1000 replicates was used to estimate 95% confidence intervals of the performance metrics, with the photo as the resampling unit. In addition, the receiver operating characteristic curves (ROCs) was plotted to illustrate the performance in screening COVID-19 disease. In the cohort from Shanghai, the participants were enrolled at the Shanghai Public Health The classification network was trained on the multicenter training dataset. The classification network achieved an AUC of 0·953 (95%CI, 0·936-0·969) in the Shanghai test dataset, an AUC of 0·866 (95%CI, 0·837-0·895) in the Hebei test dataset, and an AUC of 0·925 (95%CI, 0·873-0·976) in the Spain test dataset at image-level. The AUC of both max-voting and mean-voting strategies were shown in Table 2 . The ROCs of image-level, max-voting, and mean-voting were plotted in Figure 3 . Table 3 . However, misjudgments were also documented, The false negative rate is 30·5%, 21·9%, and 4·7% with respect to the imagelevel, mean-voting level and max-voting level. Typical ocular symptoms of COVID-19 could be captured by our specific AI model. The model successfully differentiated COVID-19 patients from non-COVID-19 controls, with higher specificity and sensitivity. Notably, the inputted eye-region images were captured by general cellphone cameras, which underlined the excellent convenience and easy accessibility of the ocular photos-based prescreening system for clinical translation. A meta-analysis demonstrated that the four most common ocular symptoms/signs were follicular conjunctivitis, redness, watering, and discharge 16 . Conjunctivitis could be the sole symptom of COVID-19 17 . Although there is a low prevalence of SARS-CoV-2 in tears collected from conjunctival swabs, it is possible to transmit via the eyes 18 . Therefore, screening of patients with conjunctival congestion by ophthalmologists was advocated during the outbreak of COVID-19 19 . In this study, we provide a non-contact method to screening the eye's manifestations, not only for ophthalmologists, but also for ordinary people. Besides the conjunctival manifestations, the SARS-CoV-2 can affect the inner and outer retinal layers, which might also contribute to the ocular symptoms, such as inflammation and ocular pain 20 . However, based on the clinical findings, the implementation of innovative changes such as AI may assist in battling against the COVID-19 infection 13 . The current model has two major components: an image preprocessing method to detect, crop, and align the eye area from the input image, and a CNN-based screen model to extract discriminative features and recognize COVID-19 patients based on the processed eye-region data. The extracted high-dimensional feature is used to compare with the prototype features in the knowledge base for classification. Because of the great ability to capture the specific eye To test whether the model can distinguish the asymptomatic COVID-19 patients from the control group. We leave only the 23 asymptomatic COVID-19 patients in the shanghai dataset (6 non-asymptomatic COVID-19 patients are removed) and make an asymptomatic COVID-19 vs. Non-COVID-19 test. The sensitivity is 72·8%, 100%, 87% on image-level, max-voting subject-level and mean-voting subject-level, which is almost the same as the sensitivity of the default COVID-19 vs Non-COVID-19 test (71·2%, 100% and 86·2% on image-level, maxvoting subject-level and mean-voting subject-level). This implies that the model can effectively distinguish the asymptomatic COVID-19 patients from the control group. In addition, this study belongs to a long-term global project . The project would gradually open more than 300 diseases eye tests, such as virus influenza, diabetes, hepatopathy, etc. through the open accessible APIs. The test algorithm could be easily deployed or embedded in the high-definition (HD) camera and any detect accessories, combined into a multi-modal approach including vision and other sensors, continually monitoring the particular disease control areas such as the transportation hub, population center, quarantine house, making the health care more accessible with lower cost. We believe this system could be easily realized with HD qualified eye-region images and selfies for rapid COVID-19 prescreening. Moreover, the current study could be inspiring and helpful for encouraging more researches on this topic. There are some limitations in this study. First, the participants were mostly collected from East Asia (China) and some from Spain. Therefore, a larger multicenter study covering more patients with diverse races and more control groups is necessary before the model could be used globally. More data are being collected and will be used in the further study. Secondary, there might be potential confounding factors such as comorbidities influencing eye symptoms. We did not collect the comorbidities of our participants. However, the control and positive patients were randomly selected from the population, which could balance the baseline demographics between groups. Third, some of the demographic information (e.g., Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review Universal screening for SARS-CoV-2 infection: a rapid review SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection Extrapulmonary manifestations of COVID-19 COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19 COVID-19 and the Ocular Surface: A Review of Transmission and Manifestations COVID-19 and the eye Ophthalmic and Neuro-ophthalmic Manifestations of Coronavirus Disease 2019 (COVID-19) Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context Ocular Manifestations of COVID-19: A Systematic Review and Meta-analysis Ocular Manifestations of Hospitalized COVID-19 Patients in a Tertiary Care Academic Medical Center in the United States: A Cross-Sectional Study Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts COVID 19 repercussions in ophthalmology: a narrative review Learnable Stroke Models for Example-based Portrait Painting A novel spontaneous facial expression recognition using dynamically weighted majority voting based ensemble classifier Manifestations and Virus Detection in the Ocular Surface of Adult COVID-19 Patients: A Meta-Analysis Conjunctivitis as sole symptom of COVID-19: A case report and review of literature Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19 Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study COVID-19: more than a respiratory virus, an optical coherence tomography study All other authors declare no competing interests. All participants were provided with written informed consent at the time of recruitment. And this study which conducted in Shanghai was approved by the Ethics Committee of Shanghai public health clinic center of Fudan University. which conducted in Spain was approved by the Ethics Committee on Drug Research of the University and Polytechnic Hospital La Fe. Not publicly available due to NDA & AIMOMICS license protection.